Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity

NCT02134613 is registered in ClinicalTrials.gov with Universidade Federal do Rio de Janeiro as lead sponsor.

NCT NCT02134613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity
Lead sponsor
Universidade Federal do Rio de Janeiro
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2017
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, psoriatic arthritis